SCHEMBL9363530

SCHEMBL9363530

CCCCCCCC(Nc1cccc2ccccc12)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 2/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CACNA2D1 P54289 1/20 0.45
TACR3 P29371 3/20 0.45
MEN1 O00255 1/20 0.41
SLC6A4 P31645 1/20 0.40
ALDH1A1 P00352 2/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP8 P22894 1/20 0.39
MMP14 P50281 1/20 0.39
CA14 Q9ULX7 1/20 0.39
EPHX1 P07099 1/20 0.39
KCNA5 P22460 1/20 0.38
CNR2 P34972 3/20 0.38
CNR1 P21554 2/20 0.38
HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19024404 1.00 KMT2A (0.51) KMT2AKDM4EL3MBTL1CACNA2D1TACR3
SCHEMBL21219044 0.93 CDC25B (0.52) KMT2AKDM4EL3MBTL1CACNA2D1TACR3
SCHEMBL19024389 0.88 RPS6KB1 (0.44) KMT2AKDM4EL3MBTL1CACNA2D1TACR3
SCHEMBL28963638 0.81 KDM4E (0.57) KMT2AKDM4EL3MBTL1CACNA2D1CA12
SCHEMBL28963762 0.81 KDM4E (0.57) KMT2AKDM4EL3MBTL1CACNA2D1CA12
SCHEMBL19024399 0.81 KDM4E (0.46) KMT2AKDM4EL3MBTL1CNR2CNR1
SCHEMBL19024392 0.81 KDM4E (0.46) KMT2AKDM4EL3MBTL1CNR2CNR1
SCHEMBL15009655 0.80 KDM4E (0.53) KMT2AKDM4EL3MBTL1CACNA2D1ALDH1A1
SCHEMBL10620293 0.80 TACR3 (0.41) KMT2AKDM4ECACNA2D1TACR3MEN1
SCHEMBL20339619 0.78 KDM4E (0.51) KMT2AKDM4EL3MBTL1CACNA2D1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106661493-B Lubricant composition, use thereof, and aliphatic ether compound 株式会社MORESCO 2020-11-13 CN claimed
EP-3257922-B1 LUBRICANT COMPOSITION, USE THEREOF AND ALIPHATIC ETHER COMPOUND MORESCO CORP (JP) 2019-08-07 EP claimed
US-9920274-B2 Lubricant composition, use thereof and aliphatic ether compound MORESCO CORPORATION (JP) 2018-03-20 US claimed
EP-3257922-A1 LUBRICANT COMPOSITION, USE THEREOF AND ALIPHATIC ETHER COMPOUND Moresco Corporation (JP) 2017-12-20 EP claimed
US-20170183598-A1 LUBRICANT COMPOSITION, USE THEREOF AND ALIPHATIC ETHER COMPOUND MORESCO CORPORATION (JP) 2017-06-29 US claimed
EP-0408506-B1 New triazole compounds CIBA GEIGY AG (CH) 1994-08-17 EP claimed
EP-0462061-B1 Triazole compounds useful as metal deactivators CIBA GEIGY AG (CH) 1994-08-10 EP claimed
CN-106661493-B Lubricant composition, use thereof, and aliphatic ether compound 株式会社MORESCO 2020-11-13 CN disclosed
EP-2617802-B1 ANTIOXIDANT COMPOSITION, AND LUBRICATING OIL COMPOSITION CONTAINING SAME ADEKA CORP (JP) 2019-09-18 EP disclosed
EP-3257922-B1 LUBRICANT COMPOSITION, USE THEREOF AND ALIPHATIC ETHER COMPOUND MORESCO CORP (JP) 2019-08-07 EP disclosed
US-9920274-B2 Lubricant composition, use thereof and aliphatic ether compound MORESCO CORPORATION (JP) 2018-03-20 US disclosed
EP-3257922-A1 LUBRICANT COMPOSITION, USE THEREOF AND ALIPHATIC ETHER COMPOUND Moresco Corporation (JP) 2017-12-20 EP disclosed
US-20170183598-A1 LUBRICANT COMPOSITION, USE THEREOF AND ALIPHATIC ETHER COMPOUND MORESCO CORPORATION (JP) 2017-06-29 US disclosed
US-9382498-B2 Antioxidant composition and lubricating oil composition containing same ADEKA CORPORATION (JP) 2016-07-05 US disclosed
EP-2617802-A1 ANTIOXIDANT COMPOSITION, AND LUBRICATING OIL COMPOSITION CONTAINING SAME Adeka Corporation (JP) 2013-07-24 EP disclosed
US-20130184190-A1 ANTIOXIDANT COMPOSITION AND LUBRICATING OIL COMPOSITION CONTAINING SAME Adeka Corporation of Tokyo (JP) 2013-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170183598-A1 LUBRICANT COMPOSITION, USE THEREOF AND ALIPHATIC ETHER COMPOUND PHOSPHO1, PLTP, NAPEPLD KMT2A 1683/4885KDM4E 1617/4885L3MBTL1 2292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.